Klee Justin B. bought AMLX
March 5, 2026 · Form 4 insider transaction
Klee Justin B. bought 373,295 shares of Amylyx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
373,295
Price
$0.00
Total value
N/A
InsiderKlee Justin B.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after373,295
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.